Journal article
Suicidal ideation in Huntington disease: The role of comorbidity
Psychiatry research, Vol.188(3), pp.372-376
08/15/2011
DOI: 10.1016/j.psychres.2011.05.006
PMCID: PMC3790459
PMID: 21605914
Abstract
Huntington disease (HD) is a neurodegenerative condition characterized by cognitive impairments, motor abnormalities, and psychiatric disturbance. An increased risk for suicide has been documented. The majority of HD research has focused on cognitive and motor features of HD; the implications of psychiatric manifestations have received less consideration. Recent studies have sought to identify the stages of HD in which patients are at increased risk to experience suicidal ideation, though no study has examined possible risk factors for suicidality. The current study examines the presence of psychiatric comorbidity and its involvement in suicidal ideation. Suicidal ideation was examined in 1941 HD patients enrolled in the Huntington Study Group. Of those, 19% (N=369) endorsed current suicidal ideation. Logistic regression analyses indicated that depression/anxiety and aggression/irritability are significant predictors of suicidal ideation. In a subsample with the greatest suicidal ideation, alcohol and drug abuse were also predictive. It is recommended that all individuals with HD (specifically those with features of depression, aggression, substance abuse) have routine suicide assessment; further research is needed to understand the high rate of suicide in HD.
Details
- Title: Subtitle
- Suicidal ideation in Huntington disease: The role of comorbidity
- Creators
- Heather H. Wetzel - Northwestern UniversityCarissa R. Gehl - VA Medical CenterLisa Dellefave–Castillo - University of ChicagoJudith F. Schiffman - Northwestern UniversityKathleen M. Shannon - Rush UniversityJane S. Paulsen - University of IowaHuntington Study Group
- Resource Type
- Journal article
- Publication Details
- Psychiatry research, Vol.188(3), pp.372-376
- DOI
- 10.1016/j.psychres.2011.05.006
- PMID
- 21605914
- PMCID
- PMC3790459
- NLM abbreviation
- Psychiatry Res
- ISSN
- 0165-1781
- eISSN
- 1872-7123
- Publisher
- Elsevier Ireland Ltd
- Grant note
- DOI: 10.13039/100000002, name: National Institutes for Health; DOI: 10.13039/100000065, name: National Institute of Neurological Disorders and Stroke, award: NS40068; DOI: 10.13039/100005725, name: CHDI Foundation, Inc
- Language
- English
- Date published
- 08/15/2011
- Academic Unit
- Psychiatry; Psychological and Brain Sciences
- Record Identifier
- 9984293755102771
Metrics
5 Record Views